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Somatic tissues in female eutherian mammals are
mosaic due to random X inactivation. In contrast to
mice, X chromosome reactivation does not occur
during the reprogramming of human female somatic
cells to induced pluripotent stem cells (iPSCs),
although this view is contested. Using balanced
populations of female Rett patient and control fibro-
blasts, we confirm that all cells in iPSC colonies
contain an inactive X, and additionally find that all
colonies made from the same donor fibroblasts con-
tain the same inactive X chromosome. Notably, this
extreme ‘‘skewing’’ toward a particular dominant,
active X is also a general feature of primary female
fibroblasts during proliferation, and the skewing
seen in reprogramming and fibroblast culture can
be alleviated by overexpression of telomerase. These
results have important implications for in vitro
modeling of X-linked diseases and the interpretation
of long-term culture studies in cancer and senes-
cence using primary female fibroblast cell lines.
INTRODUCTION
During eutherian mammalian development, females randomly
inactivate one of the two X chromosomes in a process called X
chromosome inactivation (XCI) (Lyon, 1961). Most healthy
human females consist of mosaic cell populations with respect
to XCI pattern that follow a bell-shaped curve with a median
value of 50% (Ozbalkan et al., 2005). In several heterozygous
X-linked diseases, this mosaicism ensures the survival of
females, whereas inmales, themutant gene on the single X chro-
mosome proves lethal during embryonic development.
We are interested in modeling X-linked diseases by reprog-
ramming fibroblasts from female donors. That way, one can
generate both the perfect pair of control (expressing the normal
allele) and experimental (expressing the mutant allele) cell types
for investigation of the disease phenotype. Such modeling
requires the production of cell populations exhibiting balanced
XCI and the exact strategy for achieving this depends on the
XCI status of the iPSC lines and their differentiated progeny.156 Cell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc.Murine female embryonic stem cells (ESCs) and iPSCs harbor
two active Xs, but random XCI occurs during subsequent
in vitro differentiation (Zvetkova et al., 2005; Maherali et al.,
2007). Recently, Tchieu et al. (2010) reported that reprogram-
ming of human fibroblasts is not accompanied by X chromo-
some reactivation (XCR), with the result that all cells in an iPSC
colony display the same inactive X that was inactive in the orig-
inal fibroblast. This claim was contested by Marchetto et al.
(2010) who found that iPSC colonies derived from Rett
Syndrome (RTT) patients had undergone XCR.
Here we investigate the status of the X chromosome in iPSC
colonies derived from fibroblasts of RTT patients and healthy
female controls. We confirm the results of Tchieu et al. (2010)
that XCR does not occur during reprogramming. Furthermore,
when starting from mosaic fibroblast populations with balanced
XCI, all the iPSC clones derived from individual patients exclu-
sively express the same X chromosome. We demonstrate that
expression of a particular (dominant) X chromosome confers
a distinct advantage to these cells during cellular reprogramming
and that this same population becomes predominant during
prolonged in vitro culture. Finally, we demonstrate, using various
fibroblast populations, that exogenous telomerase can prevent
skewing both in culture and during reprogramming. These
results have important implications for in vitro modeling of
X-linked diseases and the interpretation of long-term culture
studies in cancer and senescence using primary female fibro-
blast cell lines.RESULTS
Nonrandom XCI Pattern in Affected and Normal
Human iPSCs
RTT is a neurological disease in females that is mainly caused
by heterozygous mutations in the X-linked gene MeCP2. The
various knownMeCP2mutations provide an established genetic
background to investigate X chromosome dynamics during
somatic cell reprogramming. We obtained fibroblasts from two
female RTT patients: GM11272 cells (patient-72; 3 years old)
that are heterozygous for a 32 bp deletion within the 30 coding
region in the MeCP2 gene (1155 del32), and GM17880 cells
(patient-80; 5 years old) that harbor a single point mutation in the
MeCP2 methyl-binding domain (473: ACG/ ATG) (Figure 1A).
These mutations permit a clear distinction between both
X chromosomes by RT-PCR fragment size or sequencing,
Figure 1. Nonrandom X Chromosome Inac-
tivation Pattern in Human iPSCs
(A) Schematic representation of the MeCP2 gene.
Mutations in each patient are indicated.
(B) Representative iPSC colony 4–5 weeks after
infection. Phase contrast micrograph (left panel);
TRA-1-60 staining (right panel). Bars, 100 mm. See
also Figures S1 and S2.
(C) Biallelic expression ofMeCP2 in original Fib72
population (lane 1) and 12 representative iPSC
clones generated from five independent experi-
ments. All iPSC clones express themutantMeCP2
allele. Identity of WT and mutant bands was con-
firmed by sequencing analysis.
(D) Sequencing analysis for Fib80 cells reveal
biallelic MeCP2 expression. A representative
Fib80-derived iPSC clone expresses the WT
MeCP2 allele. All 13 iPSC clones derived from five
independent experiments exclusively transcribed
the WT MeCP2 allele. Eight of these iPSC clones
were generated by lentiviral infection.
(E) Sequencing analysis of two X-linked SNPs for
nonaffected fibroblasts and a representative iPSC
clone. All four iPSC clones showed the same XCI
pattern.
(F) Analysis of an X-linked SNP for iPSCs derived
from human fetal lung fibroblasts WI-38. The SNP
is recognized and cleaved by the restriction
enzyme MfeI (rs492933 CAA/GTTG). Represen-
tative WI-38-derived iPSC clones expresses the
Xd allele. All 12 iPSC clones generated from three
independent experiments showed the same XCI
pattern. In (C)–(F), bracketed numbers indicate
total number of established iPSC clones.
(G)Twomodels toaccount for the lossofmosaicism
followed by reprogramming into iPSCs. In both
models, cells expressing the Xd (blue marbles) are
reprogrammed into iPSCs more efficiently than the
other cells (red marbles). In model (i), reprogram-
ming proceeds without XCR; in model (ii), cells
undergo transient XCR (yellow marbles), but then
revert to expression of the previously active X
chromosome—a form of epigenetic memory.
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rs2805901) that we identified in the juvenile control fibroblasts al-
lowed similar discrimination by sequencing. To distinguish
between the two alleles in the well-established fetal lung fibro-
blast cell line WI-38 control, we identified an X-linked SNP
(rs492933), which is recognized and cleaved by the restriction
enzyme MfeI. We reprogrammed fibroblasts (passage 9–10)
from patient-72 (Fib72), patient-80 (Fib80), and WI-38, and
from the nonaffected, juvenile control donor, using established
protocols (Park et al., 2008; Takahashi et al., 2007). At the start
of the experiments, all donor fibroblast cultures showed
balanced XCI (left panels in Figures 1C–1F). ES-like colony
formation was monitored by morphological appearance and by
using TRA-1-60 live staining (Chan et al., 2009) 4 weeks post-
infection (Figure 1B). Picked colonies were characterized
according to published protocols (Park et al., 2008; Takahashi
et al., 2007) and met all criteria for pluripotency (Figures S1
and S2 available online).
The XCI status of the various clones was then examined
directly by taking advantage of the allelic polymorphismsdescribed above. RNAs from 14 Fib72, 13 Fib80, 12 nonaffected
WI-38, and 4 nonaffected juvenile control iPSC clones were
analyzed for XCI. Representative results are shown in Figures
1C–1F. These results indicate that only one allele was expressed
in any given iPSC clone, even when reprogrammed in more
physiological (5% O2) conditions (Figures S4C and S4D), as
reported by Tchieu et al. (2010). Strikingly and unexpectedly,
all the iPSC clones from each patient or control donors
expressed the same X chromosome (Fib72, mutant MeCP2;
Fib80, WT MeCP2; control, AGT and ACG polymorphisms;
WI-38, AAT polymorphism) (Figures 1C–1F). We will refer to
this X as the dominant X (Xd) and to the other X as the unfavored
X (Xu).
Further corroboration of XCI was obtained by transcriptional
analysis using XIST probes (XIST RNA is known to coat the inac-
tive X) (Figure S3A), and immunohistological analysis of iPSC
populations using antibodies recognizing histone H3 lysine 27
trimethylation (H3K27me3), a marker of repressive chromatin
(Figure S3B). These results confirmed XCI in the vast majority
of early-passage iPSCs. However, one clone (iPS-72-A) judgedCell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc. 157
Figure 2. One X Chromosome Confers an
Advantage during Reprogramming
(A) RT-PCR analysis of Fib72 subclones (scFib72),
expressing either the mutant or WT MeCP2 allele,
and derived iPSC clones. iPSC clones exhibit the
same XCI pattern as the original fibroblasts.
(B) Sequencing results for the original mixed
population (AC/TG; upper panel), WT subclone
(ACG; middle panel), and mutant subclones (ATG;
bottom panel) of Fib80 and derived iPSC clones.
(C) Representative alkaline phosphatase (AP)
staining of iPSCs derived from WT and mutant
subclones of Fib72 and Fib80. AP assay was
performed 4 weeks after retroviral infection.
(D) Summary of reprogramming efficiency of the
original mixed populations as assessed by alkaline
phosphatase staining (three to six independent
experiments were quantified for each subclone).
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(above) did not express XIST transcripts or exhibit H3K27me3
focus staining even upon differentiation (Figure S3; see asterisks
in panels S3B and S3C). This could be explained by the observa-
tion that female hESCs that carry an inactive X tend to lose XCI
markers during extensive passaging as a result of ‘‘culture
adaptation’’ (Dvash et al., 2010; Shen et al., 2008; Silva et al.,
2008). With extended passages (9 to 15 passages after infec-
tion), other iPSC clones lost XCI markers as well (data not
shown). Overall, these results demonstrate that a marked
skewing toward a population expressing a particular X (Xd)
chromosome occurred during reprogramming. The most likely
explanation for this reprogramming bias is that fibroblasts con-
taining a particular active X chromosome are more efficiently
reprogrammed into iPSCs. This hypothesis was confirmed by
the following experiment.
Donor fibroblasts were subcloned to prepare populations that
expressed one or the other X chromosome. These populations
were then reprogrammed into iPSC clones and the transcrip-
tional status of the X chromosome was examined. The resultant
iPSC clones always exhibited the same XCI pattern as the
original fibroblast population (Figures 2A and 2B). However, as
before, no mutant Fib80 clones were obtained and while
numerous mutant Fib72 colonies were seen, only three WT
Fib72 clones were obtained, analyzed, and shown to have the
same XCI pattern as the original fibroblast clones (Figure 2A);
two of these clones (iPS-72-DL1 and iPS-72-DL2) were fully
characterized and met all criteria for pluripotency (Figures S1
and S2). In order to provide a more quantitative reprogram-
ming comparison, the experiment was repeated using alkaline
phosphatase staining to quantify successful reprogramming.
Dramatic differences in reprogramming efficiencies were seen
between the two populations. For Fib80, clones expressing
the WT allele were reprogrammed into iPSCs at a significantly
higher efficiency (0.1%, n = 5 experiments) than mutant fibro-
blast clones (0.001%, n = 6 experiments) (Figures 2C and 2D).
Similarly, mutant subclones from Fib72 were reprogrammed at
higher efficiency (0.05%, n = 3 experiments) than WT Fib72158 Cell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc.clones (0.001%, n = 4 experiments) (Figures 2C and 2D). In
conclusion, our results indicate that not only do all cells in an
iPSC colony express the same X allele, but nearly all iPSC
clones made from the same individual donor also express that
same X allele. This suggests that the expression status of the
X chromosome endows a particular population of female
cells with a dramatic advantage or disadvantage during cellular
reprogramming.
Human Fibroblasts Skew toward the Xd upon Serial
Passaging
Because the process that inactivates X chromosomes in females
is random (Lyon, 1961; Ozbalkan et al., 2005), most females
show a balanced mosaicism. Transcript analysis of fibroblasts
from Fib72, Fib80, and fetal (IMR90 and WI-38) and juvenile
controls showed biallelic expression of X-linked genes (Figures
3A–3F), indicating that the original populations were a balanced
mosaic of cells that express either the paternal or the maternal
allele. Consistent with these results, cloning of the RTT fibroblast
populations yielded roughly equal numbers ofWT ormutant sub-
clones (data not shown). In contrast, transcript analysis of late
passaged cultures of all these cells consistently exhibited homo-
geneous X-linked expression, indicating that loss of mosaicism
occurred quite rapidly (6 to 27 cell divisions) during in vitro
passaging (Figures 3A–3F). Strikingly, in numerous independent
experiments, the skewing consistently occurred toward the
same X allele (n = 8 experiments for Fib72; n = 6 for Fib80; n =
6 for nonaffected fibroblasts #1; n = 2 for IMR90; n = 3 for non-
affected fibroblasts #2; n = 5 for WI-38; n = 2 for nonaffected
fibroblasts #3 [not shown]; a fourth juvenile control was already
skewed when we obtained the cells [not shown]). These results
demonstrate that the observed skewing is highly predictable
and not random. Interestingly, in all cases tested, the XCI skew-
ing of fibroblasts in vitro (Figures 3A–3C and 3F) precisely
mirrored the pattern seen during reprogramming to iPSCs
(Figures 1C–1F).
To further investigate the dynamics of the skewing, RNA was
collected from Fib80, WI-38, and juvenile control fibroblast
Figure 3. Nonrandom Skewing upon Serial
Passaging of Female Fibroblasts
Fibroblasts were cultured and analyzed for X
expression at different times: (A), Fib72; (B), Fib80;
(C), nonaffected control #1; (D), IMR90; (E), non-
affected control #2; and (F), WI-38. Biallelic
expression in low passage populations and
monoallelic expression (loss of mosaicism) upon
passaging is shown. One form of the SNP
rs492933 (CAATTG but not CAGTTG) is recog-
nized and cleaved by the restriction enzyme MfeI
(E and F). All clones skew in favor of the same allele
(n = 8 experiments for Fib72; n = 6 for Fib80; n = 5
for nonaffected fibroblasts #1; n = 2 for IMR90;
n = 2 for nonaffected fibroblasts #2; n = 4 for
WI-38) after27 cell divisions (D–F) or as indicated
in the figure (A–C). See also Figure S4 for skewing
in different growth conditions.
Cell Stem Cell
X Chromosome Dynamics in iPSCs and Somatic Cellspopulations after approximately three to six cell divisions.
Sequencing analysis showed a gradual, progressive shift toward
a homogenous population that expressed the same Xd chromo-
some (Figures 4A–4C and Figure S4A). These results indicate
that X-linked skewing occurs gradually during cellular
proliferation.
The data above contrast divergent transcript levels to
assess cellular skewing kinetics, butmay not allow accurate esti-
mates of the two cell populations if mutant and WT transcript
stabilities differ. Fib72 cells carry a heterozygous deletion in
the MeCP2 gene (Figure 1A), which generates a truncated
protein as a consequence of a shift in the reading frame. Due
to the location of the epitope, antibodies raised against the
MePC2 C terminus do not react with the mutant form of the
protein (Marchetto et al., 2010). This allowed us to distinguish
visually the two cell populations within a mixed culture (Fig-
ure S5B). Quantification of the ratio between the two cell popu-
lations approximately every six cell divisions showed a gradual
skewing of 1%–2% in every single cell division (Figure 4D).
This proliferative advantage of the mutant 72 cells was further
confirmed by directly studying cells undergoing DNA synthesis.
Early-passaged cultures were treated for 4 hr with the alkynyl
nucleoside analog 5-ethynyl-20-deoxyuridine (EdU). If the
expression of a particular X endows a population with a prolifer-
ative advantage, we would expect more cells in that population
to incorporate EdU during the short labeling period. Indeed, in
Fib72, double staining for EdU/MeCP2 indicated that mutant
cells have a proliferative advantage over the WT fibroblasts
(Figures S5C and S5D) with 17% ± 3% of the mutant cells
labeled as opposed to 9% ± 3% of the WT. Collectively, our
results demonstrate that the mosaic nature of female fibroblasts
is lost during extended passage in vitro as a consequence of
proliferative advantage.Cell Stem Cell 9, 156–16Skewing as described above has only
been observed in vivo in certain disease
states or in old age (see Discussion).
This indicates that some aspect of
in vitro culture leads to skewing. Many
tissues in vivo, including fibroblasts,
experience hypoxic conditions. Thus,we tested whether culture in 5% O2 (rather than 21% O2) with
or without free radical scavengers had any impact on skewing.
The results in Figures S4A and S4B show that skewing is unaf-
fected by either of these modifications.
A possible explanation for the skewing could be that cells
expressing the Xu are more prone to replicative stress and
consequently acquire critically shortened telomeres and enter
senescence earlier than cells expressing the Xd (Harley et al.,
1990). The trigger for this process seems to be the increase in
persistent DNA damage foci, which can be detected by immu-
nostaining against 53BP (Schultz et al., 2000; d’Adda di Fagagna
et al., 2003). Using 53BP staining as a measure of DNA damage,
we observe that the disadvantaged fibroblast population ex-
pressing the WT MeCP2 allele has far more DNA damage foci
than the population expressing themutantMeCP2 allele (Figures
4E and 4F). We also find (via b-gal staining) many senescent cells
in the late passage cells. Though it is very likely that these were
predominantly MeCP2 WT, for technical reasons, we could not
demonstrate this (data not shown). However, since DNA damage
foci are a prelude to cell cycle exit either through senescence or
apoptosis, it is tempting to conclude that this differentially
imposed damage is responsible for the relative loss of cells
expressing the Xu.
Exogenous Telomerase Can Prevent Skewing
in Culture and during Reprogramming
Telomere shortening can be prevented by expression of telome-
rase (Bodnar et al., 1998). To investigate whether exogenous
telomerase could prevent or delay the fibroblast skewing, we
ectopically expressed either active or catalytically impaired
human telomerase reverse transcriptase (hTERT) and tested
their effects on skewing during subsequent in vitro proliferation
(Counter et al., 1998; Hahn et al., 1999). Only populations that5, August 5, 2011 ª2011 Elsevier Inc. 159
Figure 4. Skewing as a Result of Proliferative Advantage
Gradual skewing toward one allele occurs upon serial passaging: (A) Fib80; (B) WI-38; (C) nonaffected cells; and (D) Fib72. B, balanced; S, skewed.
(D) Comparison of WT and mutant Fib72 by staining against MeCP2. A total of 7220 cells were counted. (E) Double staining of Fib72 against WTMeCP2 (red) and
53BP (green). Hoechst is shown in blue. Bars, 100 mm. (F) Quantification of low (1–2) and high (>2) DNA damage 53BP foci inWT andmutant Fib72. A total of 3214
cells were counted. See also Figure S5.
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(Figure 5). Samples containing inactive telomerase skewed after
12 (WI-38, Fib80) to36 (control #2) cell divisions (Figures 5A–
5C), as expected. Strikingly, sister dishes from all three samples,
expressing the active hTERT, stayed balanced during serial
passaging in vitro. These results suggest that active telomerase
can dramatically slow down or prevent skewing in female fibro-
blast cultures in vitro.
To test whether these immortalized (hTERT+) fibroblasts can
generate both isogenic iPSC populations that clonally express
either the paternal or the maternal X allele, we reprogrammed
WI-38 cells, ectopically expressing either active or catalytically
impaired hTERT. ES-like colony formation was monitored as
described above (not shown) and colonies were collected
4 weeks postinfection. Strikingly, both iPSC populations, ex-
pressing either the paternal or the maternal X, were obtained
from the hTERT+ population (Figure 5E). In contrast, all nine
iPSC clones, derived from hTERT fibroblasts, expressed the
same Xd allele. Finally, instead of reprogramming cells that
already expressed exogenous hTERT, we added hTERT to the160 Cell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc.reprogrammingmix and also found that we could easily generate
an isogenic hiPSC pair from Fib72 (Figure 5D). These results
suggest that hTERT expression rescues the disadvantage
conferred by expression of the Xu chromosome, during both
in vitro proliferation and reprogramming.
Restoring the Lost Population
Loss of mosaicism upon serial passaging poses an obstacle
for in vitro disease modeling (see Discussion). The remedies
described above would not work on a totally skewed population.
To restore the disadvantaged (lost) population, we forcibly
reactivated both X chromosomes by adapting protocols re-
ported by Hanna et al. (2010). These researchers demonstrated
that female human iPSCs can, under given circumstances,
acquire morphological and functional features of murine iPSCs,
including reactivation of the silenced X chromosome. XCR fol-
lowed by subsequent differentiation should theoretically restore
the mosaic nature of somatic lineages. To test this hypothesis,
we reprogrammed Fib80 fibroblasts into iPSCs using a lentivirus
carrying Oct4, Nanog, Lin28, Sox2, and a puromycin resistance
Figure 5. Ectopic Expression of Telomerase Prevents Skewing during Fibroblast Culture and Reprogramming
Analysis of allele-specific expression of SNPs from hTERT-modified fibroblasts during extended culture (A–C) and after reprogramming into iPSCs (D and E).
(A and E), WI-38; (B), control #2, and (C), Fib80 cells, ectopically expressing telomerase (hTERT) or catalytically inactive telomerase (control) after selection and
further propagation. (A) After 24 cell divisions, telomerase+ WI-38 cultures retain both alleles (two bands) whereas telomerase cells, after 12 cell divisions,
lose allele 1 (*) and skew in favor of allele 2 (arrowhead). (B) Loss of mosaicism in telomerase, but not in telomerase+, control #2 cells, as explained in (A).
(C) Retention of both alleles in Fib80 telomerase+, but not in telomerase, cells after12 cell divisions, as shown by sequencing analysis. (D and E) Isogenic iPSC
clones, expressing either Xd or Xu are generated when reprogramming: (D) Fib72 fibroblasts with five factors (hTERT plus the four Yamanaka factors), or (E),
hTERT+ WI-38 with the four Yamanaka factors. In brackets, total number of established iPSC clones is shown.
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expressed the WT allele. After one passage, iPSCs were shifted
to murine iPSC media containing human LIF with a combination
of the ERK1/2 inhibitor PD0325901, the GSK3 inhibitor
CHIR99021, and forskolin (Hanna et al., 2010) (Figure 6A). After
1 week of puromycin selection, we observed packed, dome-
like, naive iPSC colonies (Figure 6B) as well as flattened, conven-
tional hiPSCs (Figure 6C). Similar results were obtained when
established iPSCs were reinfected with the lentiviruses (data
not shown). All the human iPSC colonies expressed OCT4 (Fig-
ure 6D). Three passages after infection, most colonies were amix of cells that expressed either TRA-1-60 or stage-specific
embryonic antigen, SSEA-1, but not both (Figure 6E). Without
continuous supplementation with LIF or the inhibitors, the
dome-like iPSCs differentiated after one to three passages. We
selected individual dome-like hiPSC clones, further passaged
them with trypsin under puromycin selection, and investigated
the status of both X chromosomes at different time points by
analyzing WT and mutant MeCP2 transcripts. Analysis of
MeCP2 transcripts after infection (passage 3) still showed homo-
geneous expression. However, at later passages (passage 10)
both mutant and WT transcripts were observed, indicating thatCell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc. 161
Figure 6. Reactivation of Both X Chromo-
somes in Human iPSCs
(A) Generation of the ‘‘lost’’ fibroblast population
(blue) by XCR (orange) and subsequent differen-
tiation. ONLS: Oct4, Nanog, Lin28, and Sox2. (B)
Colony morphology of naive iPSCs and (C) normal
human iPSCs. (D and E) Immunostaining of (D)
Oct4 (green) and (E) SSEA-1 (red) + TRA-1-60
(green) in naive iPSC colonies, with Hoechst in
blue. Sanger sequencing analysis of MeCP2
transcripts in (F) naive iPSC colonies at different
passages, and in (G) secondary cells before and
after cloning is shown. Bars, 100 mm. See also
Figure S6.
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colonies lost H3K27me3 punctuate staining in pluripotent
(OCT4+) cells, but not in spontaneously differentiated (OCT4)
cells (Figures S6A–S6E). Next, we differentiated the dome-like
colonies. Although the differentiated cells obtained still ex-
pressed most of the exogeneously added genes (Figure S6F),
we were able to obtain clones that expressed either WT or
mutant MeCP2 (Figure 6G), thereby successfully restoring the
‘‘lost’’ population of somatic cells (Figure 6A and schematic in
Figure 7). These data support the conclusion that female human
iPSCs, in contrast to their murine counterparts, do not normally
reactivate X chromosomes during reprogramming, and further
refute an alternate possibility that reactivation occurs but is
unstable and quickly followed by silencing of the same X—a
form of epigenetic memory (Figure 1G (ii)).
DISCUSSION
iPSC Reprogramming and XCR
During early human development, both X chromosomes remain
active in females from the zygote stage until random XCI begins
after the blastocyst stage (Okamoto et al., 2011). As a result
human tissues are composed of a mosaic of cells that differ in
the particular X that is inactivated. During reprogramming of
mouse fibroblasts into iPSCs, XCRoccurs, resulting in two active
X chromosomes (Maherali et al., 2007). The status of the X chro-
mosomes during reprogramming of human cells into iPSCs is162 Cell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc.less clear: Tchieu et al. (2010) reported
that all cells in individual iPSC colonies
retain the same inactive X chromosome
and concluded that no XCR took place.
Marchetto et al. (2010) presented evi-
dence that iPSC colonies made from
female RTT patients contained two active
X chromosomes in most if not all the cells
(Marchetto et al., 2010), suggesting that
XCR occurs during reprogramming.
Here we have performed a detailed
investigation of the X chromosome status
in iPSC colonies derived from both RTT
patients and numerous healthy controls
and found, like Tchieu et al. (2010), that
all cells in individual iPSC colonies retain
an inactive X chromosome. This is indisagreement with Marchetto et al. (2010); however, their con-
clusion was based on the absence of specific histological
marks of the inactive X (XIST RNA coating and H3K27me3 stain-
ing) with Fib72 with no direct transcriptional assays performed.
We and others (Dvash et al., 2010; Shen et al., 2008; Silva
et al., 2008) have found that some of these histological marks
(but not X inactivation itself) can be lost during extended cell
culture. In addition, our results concur with recent data from
Cheung et al. (2011) who, like us, used transcriptional assays
to show that cells in all examined RTT iPSC colonies express
only one X chromosome. We conclude that XCR does not occur
during hiPSC reprogramming. Reprogramming of human cells
is therefore not as comprehensive as it is in murine cells.
Tchieu et al. (2010) concluded that no XCR occurs during
somatic cell reprogramming; however, they could not rule out
transient XCR followed by nonrandom XCI (see Figure 1G). To
examine this possibility, we attempted to effect XCR during
reprogramming by using hypoxic reprogramming conditions
(see Lengner et al., 2010); however, no XCR was observed. We
then deployed amodified version of the reprogramming protocol
reported by Hanna et al. (2010): using forced expression of
Lin28, Sox2, Oct4, and Nanog, we converted conventionally
prepared iPSCs into transiently stable, naive iPSCs that ex-
hibited XCR (Figure 6). Subsequent iPSC differentiation and
subcloning of the progeny yielded cells that expressed the previ-
ously Xu. These results indicate that naive human iPSCs do not
retain an epigenetic memory of the previously inactive X and
Figure 7. Model Describing the X Chromo-
some Dynamics In Vitro
In female fibroblasts, one cell population (red) has
a growth advantage over the other (blue) and
unless hTERT is ectopically expressed, mosaicism
is gradually lost upon serial passages in vitro (i).
The same disadvantaged population is repro-
grammed into iPSCs at a lower efficiency (ii), and
cannot be obtained once mosaicism is lost. Thus,
loss of one fibroblast population during passages
poses an obstacle for in vitro disease modeling.
Skewing of both iPSCs (v) and fibroblasts can be
alleviated by ectopic expression of hTERT.
Mosaicism can be restored by forced XCR (yellow)
(iii), followed by differentiation into secondary
fibroblasts (i.e., random X inactivation) (iv).
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ramming of human fibroblasts is not accompanied by XCR.
X Chromosome Skewing during Cellular
Reprogramming and In Vitro Culture
Here, we demonstrate that all cells in an individual iPSC colony
express the same X chromosome and, strikingly, nearly all colo-
nies generated from any particular donor express the same X
chromosome. In every case, the starting fibroblast population
showed a balanced mosaic of cells expressing each X chromo-
some. These observations were highly reproducible in many
separate experiments using RTT and other nonaffected fibro-
blast populations (including the well-studied WI-38 fibroblasts).
From these experiments we concluded that fibroblasts express-
ing the Xu were refractory to reprogramming.
To elucidate the reprogramming advantage conferred by a
particular X in more detail, we investigated X chromosome
dynamics during in vitro proliferation. Although starting popula-
tions of Fib72 and Fib80 fibroblasts are mosaic in the represen-
tation of each active X, this situation rapidly changes during
extended culture, and after approximately 12 population
doublings, one active X predominates. To date, we have demon-
strated skewing in two RTT patients and five nonaffected fibro-
blast populations, including WI-38 (Hayflick and Moorhead,
1961) and IMR90 cells (Nichols et al., 1977). In other instances,
we found that the populations were already skewed when we
obtained the cells. The simplest explanation for the skewing in
fibroblasts is that cells expressing the disadvantaged X enter a
quiescent, senescent, or apoptotic state earlier than their
isogenic relatives. We explored this possibility by distinguishing
between cells expressing the favored or Xu using an anti-MeCP2
antibody that only stains cells expressing the WT gene, and
demonstrate that Fib72 cells containing the Xu (expressing WT
MeCP2) proliferated more slowly and accumulated more DNA
damage than their isogenic siblings. To investigate whether the
decreased proliferative capacity and increased DNA damageCell Stem Cell 9, 156–16could be a consequence of critically
shortened telomeres, we expressed
hTERT and catalytically inactive TERT in
fibroblasts and examined X chromosome
dynamics during proliferation and reprog-
ramming. We find that hTERT (but notcatalytically inactive hTERT) alleviates skewing in proliferating
fibroblasts during the examined time period. However, we
cannot rule out that skewing might eventually occur even in cells
expressing hTERT. Importantly, however, exogenous hTERT
expression in fibroblasts (or addition of hTERT to the four reprog-
ramming factors) overturned the observed reprogramming bias
and yielded iPSC clones expressing either X. In conclusion,
these results suggest that skewing can be alleviated by elon-
gating telomeres in cells expressing the Xu, thereby preventing
telomere-associated DNA damage and senescence. It has
been shown that the efficiency of reprogramming correlates
with telomere length (Marion et al., 2009). Our results further
highlight the importance of telomere maintenance during cellular
reprogramming.
Skewing In Vitro and In Vivo
Skewing has previously been defined as a deviation of R25%
from balanced (50:50) inactivation of each parental X chromo-
some (Kubota et al., 1999; Minks et al., 2008). It has been shown
to occur in X-linked diseases (Bretherick et al., 2005; Li et al.,
2006; Lose et al., 2008; Ozbalkan et al., 2005) and 10% of
healthy females, mainly in tissues with high proliferation, such
the hematopoietic lineage (Bolduc et al., 2008; Knudsen et al.,
2007). However, skewing in dermal fibroblasts has not been
reported except in females with structural abnormalities of one
X chromosome (Carrel and Willard, 2005). We speculate that
skewing in vivo is normally prevented by a combination of low
proliferation rates and suppressive niche factors with the latter
predominant during early development when cell proliferation
is high.
We do not know why one X chromosome is superior to the
other. The human X chromosome contains over 1000 genes,
and mutations in some have been implicated in the disease-
related skewingmentionedabove. For example,DKC1, a telome-
rase subunit, is mutated in dyskeratosis congenital (Heiss et al.,
1998), and FANCB encodes a component of a complex involved5, August 5, 2011 ª2011 Elsevier Inc. 163
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anemia (Meetei et al., 2004). Thus, X-linked polymorphisms in
such genes or others with related functions could cause the
observed skewing in vitro. Alternatively, the performance of
the two Xs may be influenced by parental imprinting such that
the Xd always comes from the mother or father. We are currently
investigating this using fibroblasts from identified pedigrees.
Implications of Skewing on Disease Modeling
Disease-specific hiPSCs can theoretically differentiate into any
cell type of the human body, and offer an unprecedented oppor-
tunity to examine disease states and explore novel drug devel-
opment approaches (Colman andDreesen, 2009). Heterozygous
X-linked diseases might be particularly suitable for iPSC-based
modeling because females patients are a mosaic of cells, and
therefore, both affected (expressing the mutant allele) and WT
control (expressing the WT allele) cell types can be generated
from the same patient iPSCs. Furthermore, isogenic cell popula-
tions that solely express the WT allele could be exploited for cell
replacement therapy. Herewe show that upon reprogramming of
a balanced mosaic fibroblast population, all iPSC colonies as
well as differentiated fibroblasts exclusively express the same
X. Furthermore, we demonstrate that the in vitro-imposed bias
in reprogramming can be overcome in several ways: first, if the
patient fibroblasts are low passage and the reprogramming
experiments are large enough, iPSC clones containing the unfa-
vored, active X should be obtained, and this outcome could be
optimized if the fibroblasts are subcloned beforehand. Thismight
explain why Tchieu et al. (2010) were able to obtain isogenic
sibling iPSCs from one cell population. Second, skewing can
be prevented by expression of hTERT: reprogramming TERT+
cells or adding hTERT to the reprogramming cocktail allows
both types of isogenic iPSCs to be generated. Third, forced reac-
tivation of both X chromosomes (by overexpression of Nanog,
Lin28, Sox2, and Oct4) can generate naive iPSCs that, upon
differentiation, generate both WT and mutant cell types.
In conclusion, our finding that a particular X chromosome
confers an advantage during reprogramming highlights chal-
lenges for the in vitro modeling of X-linked disease. In addition,
our data point to the absence of telomerase being a contributory
factor to skewing in proliferating fibroblasts. Many other special-
ized cell types undergo replication in the absence of telomerase,
and these too may display a skewing phenotype. Lastly, WI-38
and IMR90 fibroblasts have been used extensively for long-
term culture studies in cancer and senescence. Our finding
that the proportion of cells expressing a particular X chromo-
some could gradually shift over the course of a study introduces
a hitherto unconsidered variable into any experimental interpre-
tation and points to the more prudent choice of male or cloned
female fibroblasts for future analyses.
EXPERIMENTAL PROCEDURES
Culture of Human Fibroblasts
RTT patient fibroblast cells (GM17880, GM11272) and WI-38 (GM06814) cells
were purchased from Coriell Cell Repositories (http://ccr.coriell.org/). IMR90
cells were purchased from ATCC. Nonaffected juvenile female fibroblasts
were a gift from Dr. Bruno Reversade. Fibroblasts were maintained in MEM
supplemented with 15% fetal bovine serum, 2 mM L-glutamine, 1% NEAA,
and antibiotic (10 mg/ml penicillin and streptomycin).164 Cell Stem Cell 9, 156–165, August 5, 2011 ª2011 Elsevier Inc.For cell immortalization, cells were transfected with retroviral construct
pBABE-Puro-DN-hTERT (catalytically inactive hTERT) or pBABE-hTERT-Neo
(obtained from Addgene) and selected with puromycin and Neomycin G418,
respectively (Counter et al., 1998; Hahn et al., 1999).
Culture of Human iPSCs and Naive iPSCs
Human iPSCs were generated according to published protocols (Takahashi
et al., 2007) with slight modifications, using retroviral vectors encoding the
human cDNAs of KLF4, SOX2, OCT4, and C-MYC (Addgene). Eight iPSC
clones from patient-80 were also derived by using lentiviral vectors encoding
the human cDNAs of OCT4, SOX2, NANOG, and LIN28 (Addgene). Infected
cells were left on the original plates in a hESC-medium (Knockout DMEM
containing 20% knockout serum replacement, 2 mM L-glutamine, 1%
NEAA, 0.1 mM b-mercaptoethanol, 1% NEAA, 0.1% antibiotic [10 mg/ml peni-
cillin and streptomycin], and 4 ng/ml bFGF) that was conditioned for 24 hr by
irradiated feeders. Medium was supplemented with 0.5 mM valproic acid
(VPA, Sigma) for 3weeks. iPSC coloniesweremanually picked after 3–4weeks
and cultured on irradiated MEF.
Naive iPSCs were produced by using a published protocol (Hanna et al.,
2010) with several modifications. Briefly, human fibroblasts, or established
iPSCs, were reprogrammed using lentiviral transgenes OSNL (OCT4, SOX2,
NANOG, and LIN28). Colonies were picked after 4 weeks and expanded
by trypsin digestion on puromycin-resistant MEF feeders containing N2B27
medium (Hanna et al., 2010) with a combination of the ERK1/2 inhibitor
PD0325901 (1 mM, Axon), the GSK3 inhibitor CHIR99021 (3 mM, Axon), and
forskolin (10 mM, Tocris Bioscience). Puromycin was added to select for
colonies that did not silence the transgenes.
RNA Isolation, Reverse Transcription, and SNP Analysis
Total RNA was extracted using the Nucleospin RNAII Kit (Macherey-Nagel)
with DNase digestion. RNA was quantified using ND-1000 spectrophotometer
(Biofrontier Technology) and first strand cDNA was produced with M-MulV
reverse transcriptase (Biolabs) using 1 mg of total RNA input. PCR was per-
formed using Supermix system (Invitrogen). Primer sequences are listed in
Table S1 available online. For sequencing analysis, cDNA was sent to 1ST
Base. To identify SNP rs492933 in WI-38 and control #2, a region of OPHN1
was amplified by PCR with primers given in Table S1 and analyzed by restric-
tion digest with Mfe1.
Immunostaining
Cells were fixed in 4% paraformaldehyde in PBS at room temperature and
blocked in 4% fetal calf serumwith 0.1% Tween 20 for 60min at room temper-
ature. Cells were then stained with primary and secondary antibodies (Invitro-
gen and Alexa Fluor, respectively) according to standard protocols. Primary
antibodies used were as follows: Oct4 (Santa Cruz, sc-5279, 1:200), MeCP2
(Sigma,m6818, 1:1000), and SSEA-1 (Santa Cruz, sc-21702, 1:500). StainAlive
antibodies TRA-1-60 (Stemgent, 09-0068) were added directly to the culture
dish for 30 min and imaged after two washes with PBS. Images were captured
with a Zeiss axiovert 200 microscope. Images were enhanced using Paint
Shop Pro software and processed evenly across the entire field using Paint
Shop Pro software.
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